Key Takeaways
- Northrop Grumman (NOC) shares declined approximately 2% following Q1 results, even after posting EPS of $6.14 versus expectations of $6.03 and revenue of $9.88 billion, representing 4.4% year-over-year growth
- Aeronautics division revenue surged 17%, primarily due to B-21 Raider stealth bomber transitioning into low-rate initial production phase
- U.S. Air Force has authorized a 25% expansion in annual B-21 manufacturing capacity
- Total backlog reaches $96 billion, while the company commits $2.5 billion toward B-21 production facilities by 2029
- Analyst consensus leans Moderate Buy, with mean price target of $743.33 suggesting approximately 29% potential upside
Northrop Grumman (NOC) delivered first-quarter results on April 21 that exceeded Wall Street expectations, yet shares retreated roughly 2% in the following session. The counterintuitive market response warrants a closer examination of the underlying factors.
Northrop Grumman Corporation, NOC
The defense contractor posted adjusted earnings per share of $6.14, surpassing analyst estimates of $6.03. Quarterly revenue reached $9.88 billion, marking a 4.4% increase year-over-year and exceeding the anticipated $9.75 billion. By conventional metrics, these results represent a decisive earnings victory.
Market participants appear concerned about a $200 million upward revision to 2026 capital spending projections and a $71 million adverse adjustment within the Space division tied to the GEM 63XL program. While neither development represents a fundamental crisis, they captured investor attention and may have prompted profit-taking.
The Aeronautics business unit emerged as the quarter’s primary growth engine. Revenue jumped 17%, propelled by the B-21 Raider stealth bomber advancing into low-rate initial production. Segment margins rebounded to 9.3%, partially attributed to the absence of loss charges that impacted results in early 2025.
Significantly, the U.S. Air Force has approved a 25% increase in annual B-21 production capacity. This decision reflects tangible demand growth rather than speculative forecasting.
The Defense Systems segment posted 5% sales growth, with the Sentinel intercontinental ballistic missile program gaining momentum. Mission Systems revenue remained essentially unchanged, though operating income advanced 20%, benefiting from favorable contract-related adjustments.
B-21 Investment Pipeline Strengthens Revenue Foundation
Company leadership disclosed plans to deploy $2.5 billion in proprietary capital toward B-21 manufacturing infrastructure through 2029. Over the previous two years, Northrop has inaugurated more than 20 new production facilities, demonstrating its commitment to scaling capacity in response to confirmed orders.
The company maintains a $96 billion contract backlog. This figure represents approximately two to three years of secured future revenue. Management established fiscal 2026 EPS guidance in the $27.40–$27.90 range, which remained essentially intact following the quarterly report.
Shares currently trade at roughly 21 times the consensus fiscal 2026 EPS estimate of $27.93. The stock’s 52-week range spans from $453.01 to $774.00, with Monday’s opening price at $575.57 — positioned below both the 50-day moving average of $699.43 and the 200-day average of $638.36.
Wall Street Maintains Constructive View
Vanguard Group expanded its NOC holdings by 1.5% during the fourth quarter, elevating its ownership stake to approximately 9.63% of outstanding shares.
Among sell-side analysts, Royal Bank of Canada lifted its price objective to $750 while maintaining an Outperform rating. Deutsche Bank holds a Buy recommendation with a $765 target. UBS reduced its target from $806 to $745 but preserved its Buy rating. Citigroup similarly adjusted its target downward from $807 to $742 while keeping a Buy stance. Jefferies shifted to a Hold rating.
The aggregate Wall Street view stands at Moderate Buy, derived from 10 Buy recommendations and five Hold ratings. Zero analysts currently assign NOC a Sell rating. The mean price target of $743.33 indicates roughly 29% appreciation potential from present trading levels.
The company also authorized a quarterly dividend of $2.31 per share, distributed on March 11, translating to an annualized payout of $9.24 and a yield of 1.6%.
The latest insider transaction involved Chief Accounting Officer Michael Hardesty selling 147 shares at $732.98 each on February 19.
